Solubilisierung stark lipophiler Arzneistoffe in lipidhaltige ...

Literaturverzeichnis
22. Hjelm, R. P., Jr., Thiyagarajan, P., und Alkan-Onyuksel, H., Organization of phosphatidylcholine
and bile salt in rodlike mixed micelles, J. Phys. Chem. 96 (1992) 8653-8661.
23. Cohen, D. E., Thurston, G. M., Chamberlin, R. A., Benedek, G. B., und Carey, M. C., LASER light
scattering evidence for a common wormlike growth structure of mixed micelles in bile salt- and
straight-chain detergent-phosphatidylcholine aqueous systems: relevance to the micellar structure
of bile, Biochemistry 37 (1998) 14798-14814.
24. Marrink, S. J. und Mark, A. E., Molecular dynamics simulations of mixed micelles modeling
human bile, Biochemistry 41 (2002) 5375-5382.
25. Roda, A., Cerre, C., Fini, A., Sipahi, A. M., und Baraldini, M., Experimental Evaluation of a Model
for Predicting Micellar Composition and Concentration of Monomeric Species in Bile Salt Binary
Mixtures, J. Pharm. Sci. 84 (1995) 593-598.
26. Coello, A., Meijide, F., Núñez, E. R., und Tato, J. V., Aggregation Behavior of Bile Salts in
Aqueous Solution, J. Pharm. Sci. 85 (1996) 9-15.
27. Haque, M. E., Das, A. R., Rakshit, A. K., und Moulik, S. P., Properties of Mixed Micelles of Binary
Surfactant Combinations, Langmuir 12 (1996) 4084-4089.
28. Penfold, J., Staples, E., Thompson, L., Tucker, I., Hines, J., Thomas, R. K., Lu, J. R., und
Warren, N., Structure and Composition of Mixed Surfactant Micelles of Sodium Dodecyl Sulfate
and Hexaethylene Glycol Monododecyl Ether and of Hexadecyltrimethylammonium Bromide and
Hexaethylene Glycol Monododecyl Ether, J. Phys. Chem. B 103 (1999) 5204-5211.
29. Barrios, J. M. und Lichtenberger, L. M., Role of biliary phosphatidylcholine in bile acid protection
and NSAID injury of the ileal mucosa in rats, Gastroenterology 118 (2000) 1179-1186.
30. El-Hariri, L., Marriott, C., und Martin, G. P., The mitigating Effects of Phosphatidilcholines on Bile
Salt- and Lysophosphatidylcholine-induced Membrane Damage, J. Pharm. Pharmacol. 44 (1992)
651-654.
31. Gould, L. A., Lansley, A. B., Brown, M. B., Forbes, B., und Martin, G. P., Mitigation of surfactant
erythrocyte toxicity by egg phosphatidylcholine, J. Pharm. Pharmacol. 52 (2000) 1203-1209.
32. Martin, G. P. und Marriott, C., Membrane damage by bile salts: the protective function of
phospholipids, J. Pharm. Pharmacol. 31 (1981) 745-759.
33. Scott Swensen, E., Milisen, B., und Curatolo, W., Intestinal Permeability Enhancement: Efficacy,
Acute Local Toxicity, and reversibility, Pharm. Res. 11 (1994) 1132-1142.
34. Naylor, L. J., Bakatselou, V., und Dressman, J. B., Comparison of the mechanism of dissolution
of hydrocortisone in simple and mixed micelle systems, Pharm. Res. 10 (1993) 865-870.
35. Naylor, L. J., Bakatselou, V., Rodriguez-Hornedo, N., Weiner, N. D., und Dressman, J. B.,
Dissolution behaviour of steroids in bile salt solutions is modified by the presence of lecithin, Eur.
J. Pharm. Biopharm. 41 (1995) 346-353.
36. Torchilin, V. P., Structure and design of polymeric surfactant-based drug delivery systems,
J. Contr. Release 73 (2001) 137-172.
37. Yalkowsky, S. H., Amidon, G. L., Florence, A. T., Repta, A. J., Roseman, T. J. und Shefter, E.,
Techniques of Solubilisation of drugs, Marcel Dekker, Inc., NY, USA, (1981).
38. Martin, A. N. und Leuenberger, H., Martin Physikalische Pharmazie. Pharmazeutisch
angewandte physikalisch-chemische Grundlagen, (4. Auflage), Wiss. Verl.-Ges. mbH (WVG),
Stuttgart, DE, (2002).
39. Huettenrauch, R., Mizellbildung als Fehlordnungsprozeß des Lösungsmittels, Acta Pharm.
Technol. 30 (1984) 181-203.
40. Hildebrand, A., Physikochemische Charakterisierung von Gallensalz-Mischmizellen als Grundlage
für innovative Arzneistoffträgersysteme, Diss., Martin-Luther-Universität Halle-Wittenberg,
DE, (2002).
41. Lennernäs, H., Nylander, S., und Ungell, A.-L., Jejunal permeability: a comparison between the
ussing chamber technique and the single-pass perfusion in humans, Pharm. Res. 14 (1997) 667-
671.
cx